Ignite Creation Date:
2025-12-25 @ 12:54 AM
Ignite Modification Date:
2025-12-25 @ 11:09 PM
Study NCT ID:
NCT00055367
Status:
COMPLETED
Last Update Posted:
2016-06-16
First Post:
2003-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease
Sponsor:
Biogen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-04
Start Date Type:
None
Primary Completion Date:
2004-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2004-05
Completion Date Type:
ACTUAL
First Submit Date:
2003-02-26
First Submit QC Date:
None
Study First Post Date:
2003-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-06-14
Last Update Post Date:
2016-06-16
Last Update Post Date Type:
ESTIMATED